We are live on ! Find out more
NVAX icon

Novavax

128 hedge funds and large institutions have $132M invested in Novavax in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 39 increasing their positions, 34 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 9

27% more call options, than puts

Call options by funds: $1.23M | Put options by funds: $964K

15% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 34

2% more funds holding

Funds holding: 126128 (+2)

0.21% less ownership

Funds ownership: 2.17%1.96% (-0.21%)

7% less capital invested

Capital invested by funds: $141M → $132M (-$9.7M)

Holders
128
Holders Change
+2
Holders Change %
+1.59%
% of All Funds
3.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
39
Reduced
34
Closed
9
Calls
$1.23M
Puts
$964K
Net Calls
+$262K
Net Calls Change
+$284K
Name Holding Trade Value Shares
Change
Change in
Stake
Federated Hermes
26
Federated Hermes
Pennsylvania
$675K +$437K +19,511 +194%
Goldman Sachs
27
Goldman Sachs
New York
$671K +$136K +6,067 +26%
TCM
28
Tekla Capital Management
Massachusetts
$651K
California Public Employees Retirement System
29
California Public Employees Retirement System
California
$647K
Canada Pension Plan Investment Board
30
Canada Pension Plan Investment Board
Ontario, Canada
$647K +$104K +4,645 +20%
RA
31
Royce & Associates
New York
$627K
AG
32
Artal Group
Luxembourg
$570K
TA
33
Teachers Advisors
New York
$568K
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$518K -$49.3K -2,202 -9%
Swiss National Bank
35
Swiss National Bank
Switzerland
$510K
D.E. Shaw & Co
36
D.E. Shaw & Co
New York
$509K -$5.67M -253,177 -92%
Wells Fargo
37
Wells Fargo
California
$509K +$118K +5,256 +31%
Creative Planning
38
Creative Planning
Kansas
$452K -$84.4K -3,768 -16%
Bank of America
39
Bank of America
North Carolina
$445K +$318K +14,192 +266%
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$399K +$3.52K +157 +0.9%
AllianceBernstein
41
AllianceBernstein
Tennessee
$354K -$129K -5,755 -27%
VEA
42
Virtus ETF Advisers
New York
$351K +$31.6K +1,410 +10%
Commonwealth Equity Services
43
Commonwealth Equity Services
Massachusetts
$340K -$716 -32 -0.2%
New York State Common Retirement Fund
44
New York State Common Retirement Fund
New York
$339K
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$258K -$6.94K -310 -3%
Invesco
46
Invesco
Georgia
$250K +$13.7K +612 +6%
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$228K
UBS Group
48
UBS Group
Switzerland
$216K +$153K +6,813 +258%
AIG
49
American International Group
New York
$215K +$15.8K +706 +8%
ProShare Advisors
50
ProShare Advisors
Maryland
$211K +$10.3K +459 +5%

NVAX Hedge Fund Activity: Q3 2017 in Review

128 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q3 2017, worth a combined $132M — down 6.9% from $141M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new NVAX positions and 9 closed out — a net gain of 3 holders — while 39 added to existing stakes and 34 trimmed.

The largest buyer was Millennium Management, adding an estimated $4.46M. The largest seller was Fidelity Investments, cutting an estimated $8M.

  • 128 institutional investors held Novavax (NVAX) as of Q3 2017, up from 126 in Q2 2017.
  • Funds reported $132M of Novavax stock for Q3 2017, down 6.9% quarter-over-quarter.
  • 12 funds opened new Novavax positions in Q3 2017 and 9 closed out, a net change of +3 holders.
  • The largest Novavax buyer in Q3 2017 was Millennium Management, an estimated $4.46M added.
  • The largest Novavax seller in Q3 2017 was Fidelity Investments, an estimated $8M sold.

Based on aggregated 13F filings for Q3 2017.